CCL20 and myasthenia gravis: Of note, CCL20, VEGFA, and TRAIL were secreted at higher levels by both resting CD4+ and CD8+ T cells in MG patients, suggesting shared pathways of T cell dysregulation that may underlie systemic inflammation in the disease.